Lucia Coraggio

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Improved glycemic control with the MiniMed 780G system in latent autoimmune diabetes and type 1 diabetes: a real-world observational study.

Improved glycemic control with the MiniMed 780G system in latent autoimmune diabetes and type 1 diabetes: a real-world observational study.

Journal: Diabetes research and clinical practice

Published: July 02, 2026

Improved glycemic control with the MiniMed 780G system in latent autoimmune diabetes and type 1 diabetes: a real-world observational study.

Improved glycemic control with the MiniMed 780G system in latent autoimmune diabetes and type 1 diabetes: a real-world observational study.

Journal: Diabetes research and clinical practice

Published: July 02, 2026

Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes.

Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes.

Journal: Cardiovascular diabetology

Published: November 21, 2024

IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes.

IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 27, 2024

No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study.

No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study.

Journal: Clinical therapeutics

Published: November 12, 2023

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study.

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study.

Journal: Diabetes, obesity & metabolism

Published: April 11, 2023

Analysis of prognostic factors in COVID-19 hospitalized patients: an Italian single-center case-control study.

Analysis of prognostic factors in COVID-19 hospitalized patients: an Italian single-center case-control study.

Journal: European review for medical and pharmacological sciences

Published: February 22, 2023

Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.

Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.

Journal: Diabetes/metabolism research and reviews

Published: August 25, 2022

Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: The CoVaDiab study I.

Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: The CoVaDiab study I.

Journal: Diabetes/metabolism research and reviews

Published: August 06, 2022

Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes.

Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes.

Journal: Diabetes research and clinical practice

Published: July 13, 2021

Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.

Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.

Journal: Diabetes, obesity & metabolism

Published: February 03, 2021

Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).

Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).

Journal: Diabetes research and clinical practice

Published: July 05, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026